JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function disease

J Allergy Clin Immunol Pract. 2021 Feb;9(2):1008-1010.e2. doi: 10.1016/j.jaip.2020.11.050. Epub 2020 Dec 5.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child, Preschool
  • Gain of Function Mutation*
  • Humans
  • Janus Kinases / antagonists & inhibitors*
  • Male
  • STAT5 Transcription Factor* / genetics
  • STAT5 Transcription Factor* / metabolism

Substances

  • STAT5 Transcription Factor
  • STAT5B protein, human
  • Janus Kinases